Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Nakaraang pagsara
NT$635.00
Sakop ng araw
NT$621.00 - NT$654.00
Sakop ng taon
NT$436.00 - NT$668.00
Market cap
96.05B TWD
Average na Volume
1.02M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (TWD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 23.26M | 164.43% |
Gastos sa pagpapatakbo | 169.15M | 26.26% |
Net na kita | -137.57M | -26.21% |
Net profit margin | -591.52 | 52.27% |
Kita sa bawat share | -0.99 | — |
EBITDA | -147.66M | -20.56% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (TWD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 9.69B | — |
Kabuuang asset | 9.80B | — |
Kabuuang sagutin | 70.23M | — |
Kabuuang equity | 9.73B | — |
Natitirang share | 153.44M | — |
Presyo para makapag-book | 10.01 | — |
Return on assets | -5.78% | — |
Return on capital | -5.84% | — |
Cash Flow
Net change in cash
| (TWD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -137.57M | -26.21% |
Cash mula sa mga operasyon | -119.47M | -80.31% |
Cash mula sa pag-invest | 19.18M | 306.83% |
Cash mula sa financing | 6.48B | 314,315.14% |
Net change in cash | 6.38B | 10,156.01% |
Malayang cash flow | -114.67M | — |
Tungkol
Itinatag
2012
Website
